SCHEMBL1902152

SCHEMBL1902152

Cn1c(SCC(=O)c2ccc(Cl)cc2)nnc1-c1cc(C(C)(C)C)nn1Cc1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.49
MAPT P10636 6/20 0.49
RAB9A P51151 5/20 0.49
NPC1 O15118 3/20 0.49
LMNA P02545 3/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
HTT P42858 1/20 0.49
THRB P10828 1/20 0.49
CDC25A P30304 1/20 0.45
CDC25B P30305 1/20 0.45
PKM P14618 1/20 0.45
POLB P06746 3/20 0.44
USP2 O75604 1/20 0.44
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALPG P10696 1/20 0.42
CPB1 P15086 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7739182 0.94 ALDH1A1 (0.48) ALDH1A1MAPTRAB9ANPC1LMNA
SCHEMBL1902320 0.92 ALDH1A1 (0.55) ALDH1A1MAPTRAB9ANPC1LMNA
SCHEMBL1900261 0.87 ALDH1A1 (0.61) ALDH1A1MAPTRAB9ANPC1LMNA
SCHEMBL1901778 0.84 ALDH1A1 (0.46) ALDH1A1MAPTRAB9ALMNAHTT
SCHEMBL7744777 0.81 ALDH1A1 (0.54) ALDH1A1MAPTRAB9ALMNAHTT
SCHEMBL3077227 0.80 ALDH1A1 (0.47) ALDH1A1MAPTRAB9ANPC1MEN1
SCHEMBL3058653 0.79 ALDH1A1 (0.42) ALDH1A1MAPTRAB9ANPC1MEN1
SCHEMBL1897557 0.79 RAB9A (0.52) ALDH1A1MAPTRAB9ANPC1MEN1
SCHEMBL3077801 0.76 ALDH1A1 (0.48) ALDH1A1MAPTHTTPKMMAPK1
SCHEMBL4201147 0.72 POLB (0.76) ALDH1A1MAPTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030171403-A1 Blockade of voltage dependent sodium channels UNIVERSITY COLLEGE LONDON (GB) 2003-09-11 US claimed
EP-1252156-B1 BLOCKADE OF VOLTAGE DEPENDENT SODIUM CHANNELS UCL BUSINESS PLC (GB) 2011-05-04 EP disclosed
US-7790761-B2 Blockade of voltage dependent sodium channels UNIVERSITY COLLEGE LONDON (GB) 2010-09-07 US disclosed
US-20060100248-A1 Blockade of voltage dependent sodium channels GARTHWAITE GITI 2006-05-11 US disclosed
US-7009056-B2 Blockade of voltage dependent sodium channels UNIVERSITY COLLEGE LONDON (GB) 2006-03-07 US disclosed
US-20030171403-A1 Blockade of voltage dependent sodium channels UNIVERSITY COLLEGE LONDON (GB) 2003-09-11 US disclosed
EP-1252156-A1 BLOCKADE OF VOLTAGE DEPENDENT SODIUM CHANNELS University College London (GB) 2002-10-30 EP disclosed
WO-2001057024-A1 BLOCKADE OF VOLTAGE DEPENDENT SODIUM CHANNELS UNIVERSITY COLLEGE LONDON (GB) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171403-A1 Blockade of voltage dependent sodium channels CACNA1F, SCNN1B, CACNA1B ALDH1A1 1123/4885MAPT 1326/4885RAB9A 1482/4885
US-20060100248-A1 Blockade of voltage dependent sodium channels CACNA1I, CACNA1F, CACNA1C ALDH1A1 1193/4885MAPT 1289/4885RAB9A 1563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.